Skip to content
Ancell Corporation
Search
  • Shopping Cart
  • Contact Us / US Orders
  • International Orders
  • Terms
Ancell Corporation
Search
  • Home
  • Shopping Cart
  • Contact Us /US Orders
  • International Orders
  • Terms
  • Procedures
  • Material Safety Data Sheet (MSDS)
  • Hot Topics
  • Home
  • Products
    • New Products
    • Anti-Human Antibodies
    • Anti-Mouse Antibody
    • Cytokine related
    • Immune Checkpoint
    • Isotype Controls
    • Progenitor/Stem Cell
    • Recombinant Proteins
    • Second-Step Reagents
    • TNF Superfamily
  • Information
    • Hot Topics
    • US Orders / Price lists
    • International Orders
    • Procedures
    • MSDS

The CD2 – CD58(LFA3) interaction is the main co stimulatory pathway for CD28- Effector T cells

By room34 / July 27, 2015

“CD58/CD2 Is the Primary Costimulatory Pathway in Human CD28−CD8+ T Cells”   J Leitner, P Steinberger, et al. (2015) J Immunol 195(2): 477-87. PMID: 26041540.

 

Related Ancell Research Products

anti-CD2 mAb         (clone 1E7E8 UMCD2)

anti-CD58(LFA-3)   (clone TS2/9)

← Previous Post
Next Post →

All prices are in U.S. dollars. International prices may vary.

Copyright © 2025 Ancell Corporation. All rights reserved.